- Have any questions?
- (561)493-4000
Purified Water TOC Testing
Manufacturing Facility Systems – USP <643> Compliance
Capzer Pharmaceuticals conducts Total Organic Carbon (TOC) analysis for purified water, water for injection (WFI), and clean steam systems used in pharmaceutical manufacturing facilities. Our FDA/DEA-registered laboratory verifies organic impurity levels supporting system qualification, routine monitoring, and validation per USP <643> requirements.
Samples undergo high-temperature combustion or wet-chemical oxidation followed by nondispersive infrared (NDIR) detection of generated CO₂, calibrated against potassium hydrogen phthalate standards (500 ppbC). USP <643> specifies ≤500 ppb for PW and ≤30 ppbC for WFI, with system suitability checks ensuring <15% drift between pre- and post-sample System Suitability Standards.
Partners achieve cGMP-compliant water system documentation for Gabapentin tablet and Empagliflozin API manufacturing from our ISO 17025-accredited facility, preventing batch release holds due to organic excursions.
Our expert team is here to support you with reliable pharmaceutical testing, analytical solutions, and regulatory guidance. Whether you have a query or need a customized service, we’re ready to assist you at every step.